Bicodon bias can determine the role of synonymous SNPs in human diseases

Abstract

BackgroundFor a long time synonymous single nucleotide polymorphisms were considered as silent mutations. However, nowadays it is well known that they can affect protein conformation and function, leading to altered disease susceptibilities, differential prognosis and/or drug responses, among other clinically relevant genetic traits. This occurs through different mechanisms: by disrupting the splicing signals of precursor mRNAs, affecting regulatory binding-sites of transcription factors and miRNAs, or by modifying the secondary structure of mRNAs.ResultsIn this paper we considered 22 human genetic diseases or traits, linked to 35 synonymous single nucleotide polymorphisms in 27 different genes. We performed a local sequence context analysis in terms of the ribosomal pause propensity affected by synonymous single nucleotide polymorphisms. We found that synonymous mutations related to the above mentioned mechanisms presented small pause propensity changes, whereas synonymous mutations that were not related to those mechanisms presented large pause propensity changes. On the other hand, we did not observe large variations in the codon usage of codons associated with these mutations. Furthermore, we showed that the changes in the pause propensity associated with benign sSNPs are significantly lower than the pause propensity changes related to sSNPs associated to diseases.ConclusionsThese results suggest that the genetic diseases or traits related to synonymous mutations with large pause propensity changes, could be the consequence of another mechanism underlying non-silent synonymous mutations. Namely, alternative protein configuration related, in turn, to alterations in the ribosome-mediated translational attenuation program encoded by pairs of consecutive codons, not codons. These findings shed light on the latter mechanism based on the perturbation of the co-translational folding process.Electronic supplementary materialThe online version of this article (doi:10.1186/s12864-017-3609-6) contains supplementary material, which is available to authorized users.

Codon usage regulates human KRAS expression at both transcriptional and translational levels

“…tions (11,61,62), our study suggests how these mutations can contribute to disease progression without altering amino acid sequences.…”

SARS-CoV-2 codon usage bias downregulates host expressed genes with similar codon usage

“…It is assumed that rare and common codons are defined by usage rates of highly expressed genes. On the other hand, it is known that synonymous variations in a coding sequence can affects its folding and/or resulting expression level (26). However, whether the codon composition of viral ORFome can affect the translation rate of host genes has not been thoroughly explored.…”

“…Virus genomes have also preference in the codon usage, but in this case the bias is constrained by the host translational machinery (38). The effects of codon composition of a transcript on its translation have been reported in literature (34,13,26,39), and is considered an important determinant of gene expression (41,42,46). However, the codon usage of a gene also affects the translation of other genes (12).…”

Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives

“…As a result, the rate and efficiency of the protein translation are increased [14,23,40]. However, the clinical application in humans is controversial, because in the last years it has been documented that synonymous mutations affect protein functions, and alterations in translation kinetics can lead to alterations in protein conformation [40][41][42][43].…”